Their struggling penalty kill was outstanding, killing off all six opportunities handed to the Sabres, but the big story of the night was the play of Jakob Pelletier. Pelletier began the game on the ...
Pierre Lemaître est de retour dans les librairies avec la sortie le 21 janvier 2025 de « Un Avenir radieux ». Il s’agit du troisième volet de la trilogie Les Années glorieuses.
Aurous Resources, the South African mining group that owns and operates the Blyvoor gold mine in Gauteng’s West Rand, today announced it has secured approval from the US Securities and Exchange ...
Rigel will mail the definitive proxy statement/prospectus to shareholders of record as of the close of business on January 10, 2025. Rigel will hold its Extraordinary General Meeting (the ...
Rigel Pharmaceuticals (RIGL) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces ...
AUROUS Resources, the South African business that controls the historic Blyvooruitzicht mine, has received regulatory approval to merge with Rigel Resource Acquisition Group, a deal that would pave ...
Jakob Pelletier had two goals and an assist, helping the Calgary Flames beat the Chicago Blackhawks 5-2 on Monday night. Mikael Backlund, Yegor Sharangovich and Jake Bean also scored for Calgary ...
Jakob Pelletier a réussi le premier match de trois points de sa carrière dans une victoire de 5 à 2 des Flames de Calgary sur les Blackhawks de Chicago, lundi soir au United Center. Accompagné ...
Copyright 2025 The Associated Press. All Rights Reserved. Calgary Flames left wing Jakob Pelletier, center, celebrates his goal against the Chicago Blackhawks with ...
CHICAGO (AP) — Jakob Pelletier had two goals and an assist, helping the Calgary Flames beat the Chicago Blackhawks 5-2 on Monday night. Flames forward Rory Kerins had two assists — both in the ...
SOUTH SAN FRANCISCO, Calif., Jan. 13, 2025 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and cancer, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback